Kim Parnell

97PUBLICATIONS
144CO-AUTHORS
PharmacogenomicsFluid-structure interaction and aeroacousticsDisease surveillanceEpidemiological methodsLabour law
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (97)

|Jul 14, 2026
Pushing the Boundaries of Topical Therapy in Patients with Atopic Dermatitis: A Review of Baseline Disease Severity and Burden in Clinical Trials.

|Jun 11, 2026
Roflumilast foam versus vehicle foam for seborrheic dermatitis (STRATUM clinical study): a plain language summary.

|Jun 11, 2026
Long-term treatment of atopic dermatitis with roflumilast cream 0.15% in patients aged 6 years or older (INTEGUMENT-OLE clinical study): a plain language summary.

|May 21, 2026
Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials.

|Dec 26, 2025
Randomized, double-blind treatment withdrawal or continuation with ruxolitinib cream in vitiligo: findings from the Topical Ruxolitinib Evaluation in Vitiligo (TRuE-V) long-term extension phase III study.

John E Harris, Kim Papp, Khaled Ezzedine

|Dec 17, 2025
Open-label treatment extension of ruxolitinib cream in vitiligo: findings from the Topical Ruxolitinib Evaluation in Vitiligo (TRuE-V) long-term extension phase III study.

John E Harris, Kim Papp, Khaled Ezzedine

Pageof 17

Frequent Collaborators

17 joint publications

Melinda J Gooderham

15 joint publications

Andrew Blauvelt

10 joint publications

Jonathan I Silverberg

9 joint publications

Ronald Vender